Enhanced differentiation and mineralization of human fetal osteoblasts on PDLLA containing Bioglass® composite films in the absence of osteogenic supplements

Journal of Biomedical Materials Research - Part A

Volumn 80, Issue 4, 2007, Pages 837-851

  Tsigkou, O ^a   Hench, L L ^a   Boccaccini, A R ^a   Polak, J M ^a   Stevens, M M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bioglass ; Fetal osteoblasts; Mineralization; Polymer bioactive glass composites

Indexed keywords

BIOGLASS®; FETAL OSTEOBLASTS; MINERALIZATION; POLYMER-BIOACTIVE GLASS COMPOSITES;

BONE; CARBOXYLIC ACIDS; COLLAGEN; SCANNING ELECTRON MICROSCOPY; TISSUE;

CELLS;

ALIZARIN RED S; ALKALINE PHOSPHATASE; BIOACTIVE GLASS; BIOMATERIAL; BONE SIALOPROTEIN; COLLAGEN TYPE 1; GLASS; OSTEOCALCIN; POLYLACTIDE; POLYSTYRENE; UNCLASSIFIED DRUG; VINCULIN;

ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; COMPOSITE MATERIAL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FETUS; FILM; FOCAL ADHESION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MINERALIZATION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPE; STAINING; TISSUE CULTURE;

ANTIGENS, DIFFERENTIATION; BONE REGENERATION; BONE SUBSTITUTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FETUS; GLASS; HUMANS; MATERIALS TESTING; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS;

EID: 33847237612     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30910     Document Type: Article

References (59)

1. Vacanti CA, Bonassar LJ. An overview of tissue engineered bone. Clin Orthop Relat Res 1999;(Suppl 367):S375-S381.
2. Petite H, Viateau V, Bensaid W, Meunier A, de Pollak C, Bourguignon M, Oudina K, Sedel L, Guillemin G. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963.
3. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
4. Vacanti CA, Vacanti JP. The science of tissue engineering. Orthop Clin North Am 2000;31:351-356.
5. Ducheyne P. Stimulation of biological function with bioactive glass. MRS Bull 1998;23:43-49.
6. Hench LL. Biomaterials. Science 1980;208:826-831.
7. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-1017.
8. Peter SJ, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Polymer concepts in tissue engineering. J Biomed Mater Res 1998;43:422-427.
9. Maquet V, Martin D, Malgrange B, Franzen R, Schoenen J, Moonen G, Jerome R. Peripheral nerve regeneration using bioresorbable macroporous polylactide scaffolds. J Biomed Mater Res 2000;52:639-651.
10. Griffith LG, Grodzinsky AJ. Advances in biomedical engineering. JAMA 2001;285:556-561.
11. Cohen S, Bano MC, Cima LG, Allcock HR, Vacanti JP, Vacanti CA, Langer R. Design of synthetic polymeric structures for cell transplantation and tissue engineering. Clin Mater 1993;13:3-10.
12. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-486.
13. Ma PX, Zhang R, Xiao G, Franceschi R. Engineering new bone tissue in vitro on highly porous poly(α-hydroxyl adds)/hydroxyapatite composite scaffolds. J Biomed Mater Res 2001;4:284-293.
14. Peter SJ, Miller ST, Zhu G, Yasko AW, Mikos AG. In vivo degradation of a poly(propylene fumarate)/β-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998;41:1-7.
15. Gheysen G, Ducheyne P, Hench LL, de Meester P. Bioglass composites: A potential material for dental application. Biomaterials 1983;4:81-84.
16. Hench LL, Wilson J. Biocompatibility of silicates for medical use. Ciba Found Symp 1986;121:231-246.
17. Hench LL. Bioactive ceramics. Ann N Y Acad Sci 1988;523:54-71.
18. Merwin GE, Atkins JS, Wilson J, Hench LL. Comparison of ossicular replacement materials in a mouse ear model. Otolaryngol Head Neck Surg 1982;90:461-469.
19. Yang XB, Roach HI, Clarke NM, Howdle SM, Quirk R, Shakesheff KM, Oreffo RO. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001;29:523-531.
20. Hench LL. Bioactive materials: The potential for tissue regeneration. J Biomed Mater Res 1998;41:511-518.
21. Jones JR, Sepulveda P, Hench LL. Dose-dependent behavior of bioactive glass dissolution. J Biomed Mater Res 2001;58:720-726.
22. Kaufmann EA, Ducheyne P, Shapiro IM. Effect of varying physical properties of porous, surface modified bioactive glass 45S5 on osteoblast proliferation and maturation. J Biomed Mater Res 2000;52:783-796.
23. Livingston T, Ducheyne P, Garino J. In vivo evaluation of a bioactive scaffold for bone tissue engineering. J Biomed Mater Res 2002;62:1-13.
24. Bielby RC, Christodoulou IS, Pryce RS, Radford WJ, Hench LL, Polak JM. Time- and concentration-dependent effects of dissolution products of 58S sol-gel bioactive glass on proliferation and differentiation of murine and human osteoblasts. Tissue Eng 2004;10:1018-1026.
25. Bosetti M, Zanardi L, Hench LL, Cannas M. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res A 2003;64:189-195.
26. Gough JE, Jones JR, Hench LL. Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 2004;25:2039-2046.
27. Loty C, Sautier JM, Tan MT, Oboeuf M, Jallot E, Boulekbache H, Greenspan D, Forest N. Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. J Bone Miner Res 2001;16:231-239.
28. Silver IA, Deas J, Erecinska M. Interactions of bioactive glasses with osteoblasts in vitro: Effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 2001;22:175-185.
29. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: Implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329.
30. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
31. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001;5:151-157.
32. Valerio P, Pereira MM, Goes AM, Leite MF. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004;25:2941-2948.
33. Stamboulis A, Hench LL, Boccaccini AR. Mechanical properties of biodegradable polymer sutures coated with bioactive glass. J Mater Sci Mater Med 2002;13:843-848.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδ C(T)) method. Methods 2001;25:402-408.
35. Mansell JP, Yarram SJ, Brown NL, Sandy JR. Type I collagen synthesis by human osteoblasts in response to placental lactogen and chaperonin 10, a homolog of early-pregnancy factor. In Vitro Cell Dev Biol Anim 2002;38:518-522.
36. Risteli J, Risteli L. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol 1995;22:77-81.
37. Montjovent MO, Burri N, Mark S, Federici E, Scaletta C, Zambelli PY, Hohlfeld P, Leyvraz PF, Applegate LL, Pioletti DP. Fetal bone cells for tissue engineering. Bone 2004;35:1323-1333.
38. Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME, Spelsberg TC. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER α cells: Bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem 2002;87:9-15.
39. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R. Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on Bioglass-filled polylactide foams. J Biomed Mater Res A 2003;66:335-346.
40. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477,478.
41. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials 2000;21:667-681.
42. Cooper LF, Masuda T, Yliheikkila PK, Felton DA. Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies. Int J Oral Maxillofac Implants 1998;13:163-174.
43. Gronowicz G, McCarthy MB. Response of human osteoblasts to implant materials: Integrin-mediated adhesion. J Orthop Res 1996;14:878-887.
44. Etienne-Manneville S, Hall A. ρ GTPases in cell biology. Nature 2002;420:629-635.
45. Huang J, Di Silvio L, Wang M, Tanner KE, Bonfield W. In vitro mechanical and biological assessment of hydroxyapatite-reinforced polyethylene composite. J Mater Sci Mater Med 1997;8:775-779.
46. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR. PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: An in vitro cell biology assessment. Biomaterials 2004;5:3013-3021.
47. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science 2005;310:1135-1138.
48. Horton MA, Townsend P, Nesbitt S. Cell surface attachment molecules in bone. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press; 2002. pp 265-286.
49. Stein GS, Lian JB, Stein JL, Van Wijnen AJ, Montecino M. Transcriptional control of osteoblast growth and differentiation. Physiol Rev 1996;76:593-629.
50. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990;143:213-221.
51. Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 1992;7:235-246.
52. Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994;9:843-854.
53. Otsuka E, Yamaguchi A, Hirose S, Hagiwara H. Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid. Am J Physiol Cell Physiol 1999;277: C132-C138.
54. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143:420-430.
55. Hench LL, Xynos ID, Polak JM. Bioactiveglasses for in situ tissue regeneration. J Biomater Sci Polym Ed 2004;15:543-562.
56. Lian JB, Stein GS. The cells of bone. In Seibel MJ, Robins SP, Bilezikian JP, editors. Dynamics of Bone and Cartilage Metabolism. San Diego: Academic Press; 1999. pp 165-179.
57. Stangenberg L, Schaefer DJ, Buettner O, Ohnolz J, Mobest D, Horch RE, Stark GB, Kneser U. Differentiation of osteoblasts in three-dimensional culture in processed cancellous bone matrix: Quantitative analysis of gene expression based on real-time reverse transcription-polymerase chain reaction. Tissue Eng 2005;11:855-864.
58. Rossert J, de Crombrugghe B. Type I collagen: Structure, synthesis and regulation. In Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. San Diego: Academic Press; 2002 pp 189-210.
59. Lynch MP, Stein JL, Stein GS, Lian JB. The influence of Type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 1995;216:35-45.